Nuclear receptors: Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
E: Ligand binding domain (LBD) containing an <scene name='54/543362/Cv/3'>active site</scene> which binds intramolecularly the N-terminal FXXFL motif or coactivators with the same motif (Human androgen receptor ligand-binding domain complex with modulator; PDB code [[3b5r]]).<ref>PMID:18805694</ref> Water molecules are shown as red spheres. <br /> | E: Ligand binding domain (LBD) containing an <scene name='54/543362/Cv/3'>active site</scene> which binds intramolecularly the N-terminal FXXFL motif or coactivators with the same motif (Human androgen receptor ligand-binding domain complex with modulator; PDB code [[3b5r]]).<ref>PMID:18805694</ref> Water molecules are shown as red spheres. <br /> | ||
F: C-terminal domain | F: C-terminal domain | ||
See also [[Receptor]] | |||
'''Family members (~ according to [https://en.wikipedia.org/wiki/Nuclear_receptor]):''' | '''Family members (~ according to [https://en.wikipedia.org/wiki/Nuclear_receptor]):''' |
Revision as of 16:22, 4 April 2021
Under development!!! Nuclear receptor structure is composed of 5 domains - A/B: N-terminal regulatory domain contains activation function 1 (residues 101-370), activation function 5 (residues 360-485) and dimerization surface (residues 1-36 and 370-494). See also Receptor Family members (~ according to [1]): Thyroid Hormone Receptor-likeThyroid hormone receptorRetinoic acid receptor
Peroxisome Proliferator-Activated ReceptorsPPARγ
Liver X receptor-likeLiver X receptorBile acid receptor (Farnesoid X receptor)Vitamin D receptor-likeVitamin D receptorPregnane X receptor
Retinoid X Receptor-likeRetinoid X receptor
Estrogen Receptor-likeEstrogen receptorEstrogen receptor alpha
Estrogen receptor beta3-Ketosteroid receptorsGlucocorticoid receptorMineralocorticoid receptorProgesterone receptorAndrogen receptorLiver receptor homolog-1? |
|
ReferencesReferences
- ↑ Bohl CE, Wu Z, Chen J, Mohler ML, Yang J, Hwang DJ, Mustafa S, Miller DD, Bell CE, Dalton JT. Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators. Bioorg Med Chem Lett. 2008 Oct 15;18(20):5567-70. Epub 2008 Sep 5. PMID:18805694 doi:10.1016/j.bmcl.2008.09.002
- ↑ Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y